Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!

被引:14
|
作者
Fuchs, Charles S. [1 ]
Ogino, Shuji [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED-TRIAL; BETA-CATENIN; COLON-CANCER; ADENOMAS; PATHWAY; PREVENTION; ACTIVATION; EXPRESSION;
D O I
10.1200/JCO.2013.52.0080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:4358 / 4361
页数:4
相关论文
共 50 条
  • [1] Aspirin, PIK3CA Mutation, and Colorectal-Cancer Survival
    Sahin, Ibrahim H.
    Garrett, Christopher
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 289 - 289
  • [2] Aspirin and PIK3CA Mutations in Colorectal Cancer
    Kirstein, M. M.
    Vogel, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 306 - 307
  • [3] Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
    Liao, Xiaoyun
    Lochhead, Paul
    Nishihara, Reiko
    Morikawa, Teppei
    Kuchiba, Aya
    Yamauchi, Mai
    Imamura, Yu
    Qian, Zhi Rong
    Baba, Yoshifumi
    Shima, Kaori
    Sun, Ruifang
    Nosho, Katsuhiko
    Meyerhardt, Jeffrey A.
    Giovannucci, Edward
    Fuchs, Charles S.
    Chan, Andrew T.
    Ogino, Shuji
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1596 - 1606
  • [4] Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?
    Amatu, Alessio
    Bencardino, Katia
    Sartore-Bianchi, Andrea
    Siena, Salvatore
    ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [5] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    ONCOTARGET, 2017, 8 (14) : 22305 - 22306
  • [6] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [7] PIK3CA mutation and methylation influences the outcome of colorectal cancer
    Iida, Satoru
    Kato, Shunsuke
    Ishiguro, Megumi
    Matsuyama, Takatoshi
    Ishikawa, Toshiaki
    Kobayashi, Hirotoshi
    Higuchi, Tetsuro
    Uetake, Hiroyuki
    Enomoto, Masayuki
    Sugihara, Kenichi
    ONCOLOGY LETTERS, 2012, 3 (03) : 565 - 570
  • [8] Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer
    Church, D.
    Domingo, E.
    Sieber, O.
    Ramamoorthy, R.
    Davidson, B.
    Kerr, D. J.
    Midgley, R.
    Tomlinson, I. P. M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S484 - S484
  • [9] PIK3CA mutation in colorectal cancer:: Relationship with genetic and epigenetic alterations
    Nosho, Katsuhiko
    Kawasaki, Takako
    Ohnishi, Mutsuko
    Suemoto, Yuko
    Kirkner, Gregory J.
    Zepf, Dimity
    Yan, Liying
    Longtine, Janina A.
    Fuchs, Charles S.
    Ogino, Shuji
    NEOPLASIA, 2008, 10 (06): : 534 - 541
  • [10] Clinicopathologic and molecular associations of PIK3CA and PTEN mutation in colorectal cancer
    Day, Fiona Lee
    Desai, Jayesh
    Jorissen, Robert N.
    Gibbs, Peter
    Mouradov, Dmitri
    Li, Shan
    Sieber, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)